DEBORAH POCHE: Open Payments
NPI 1619480670 · PLAINVILLE, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$915 in 37 payments from 18 companies in 2025. Trend: 2023 $547 · 2024 $566 · 2025 $915
Food & beverage: $915
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $184 |
| PFIZER INC. | 6 | $138 |
| Lilly USA, LLC | 3 | $77 |
| CORDIS US CORP. | 2 | $68 |
| Edwards Lifesciences Corporation | 2 | $62 |
| Novo Nordisk Inc | 2 | $56 |
| GlaxoSmithKline, LLC. | 2 | $49 |
| Verona Pharma, Inc. | 2 | $38 |
| ABIOMED | 1 | $38 |
| Alnylam Pharmaceuticals Inc. | 2 | $36 |
Products named: ELIQUIS, AIRSUPRA, ZEPBOUND, Wegovy, SHINGRIX, AQUATRACK, Ohtuvayre, ONPATTRO.
Industry payments across MA — which companies pay providers there.
